Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Oncologic Essentials in Malignant Cardiac Masses (Approach and Follow-Up) Publisher



Parkhideh S1 ; Mousavi SA2
Authors
Show Affiliations
Authors Affiliations
  1. 1. RIOHCT, TUMS, Tehran, Iran
  2. 2. Hematology-Oncology and Stem Cell Transplantation Research Center, Tehran University of Medical Sciences, Tehran, Iran

Source: Multimodal Imaging Atlas of Cardiac Masses Published:2022


Abstract

• Malignant cardiac tumors are extremely rare. • 25% of primary cardiac tumors are malignant. • Most malignant cardiac tumors are metastatic (from breast, lung, melanoma, soft tissue sarcoma, etc.). • Sarcoma, lymphoma, and malignant pericardial mesothelioma are three main primary malignant cardiac tumors. • Usual imaging studies consist of TTE, CMR, and contrast TTE that are helpful noninvasive tools to diagnose suspicious cardiac masses. • Generally, despite multimodal treatment strategies, prognosis of malignant cardiac tumors is poor. © 2023 Elsevier Inc. All rights reserved.
Related Docs
1. History and Physical Examination of Different Cardiac Masses, Multimodal Imaging Atlas of Cardiac Masses (2022)
2. Oncologic Essentials in Benign Cardiac Masses (Approach and Follow-Up), Multimodal Imaging Atlas of Cardiac Masses (2022)
3. Bloody Pericardial Effusion With a Huge Pericardial Mass: A Case Report, Journal of Tehran University Heart Center (2020)
Experts (# of related papers)